Gene transfer to coronary artery bypass conduits

Annals of Thoracic Surgery

Volumn 74, Issue 4, 2002, Pages 1161-1166

  Chiu Pinheiro, Cynthia K ^a   O'Brien, Timothy ^a   Katusic, Zvonimir S ^a   Bonilla, Luis F ^a   Hamner, Chad E ^a   Schaff, Hartzell V ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DOG; GENE TRANSFER; MALE; NONHUMAN; PRIORITY JOURNAL; SAPHENOUS VEIN GRAFT; TISSUE DISTRIBUTION; TRANSGENE;

ADENOVIRIDAE; ANIMALS; BETA-GALACTOSIDASE; CORONARY ARTERY BYPASS; CORONARY STENOSIS; DOGS; ESCHERICHIA COLI; GENE TRANSFER TECHNIQUES; MALE; SAPHENOUS VEIN; TRANSGENES;

EID: 0036797985     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(02)03831-6     Document Type: Article

References (30)

1. Fitzgibbon GM, Kafka HP, Leach AJ, Keon WJ, Hooper GD, Burton JR. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol 1996;28:616-26.
2. Motwani JG, Topol EJ. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation 1998;97:916-31.
3. Reardon MJ, Conklin LD, Reardon PR, Baldwin JC. Coronary artery bypass conduits: review of current status. J Cardiovasc Surg (Torino) 1997;38:201-9.
4. Mehta D, Izzat MB, Bryan AJ, Angelini GD. Towards the prevention of vein graft failure. Int J Cardiol 1997;62(Suppl 1):S55-63.
5. Fuster V, Badimon L, Badimon JJ, Ip JH, Chesebro JH. The porcine model for the understanding of thrombogenesis and atherogenesis. Mayo Clin Proc 1991;66:818-31.
6. Israel DH, Adams PC, Stein B, Chesebro JH, Fuster V. Antithrombotic therapy in the coronary vein graft patient. Clin Cardiol 1991;14:283-95.
7. Fuster V, Chesebro JH. Role of platelets and platelet inhibitors in aortocoronary artery vein graft disease. Circulation 1986;73:227-32.
8. Chesebro JH, Fuster V, Elveback LR, et al. Effect of dipyridamole and aspirin on late vein graft patency after coronary bypass operations. N Engl J Med 1984;310:209-14.
9. Chesebro JH, Clements IP, Fuster V, et al. A platelet inhibitor drug trial in coronary artery bypass operations: benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein graft patency. N Engl J Med 1982;307:73-8.
10. Metke MP, Lie JT, Fuster V, Josa M, Kaye MP. Reduction of intimal thickening in canine coronary bypass vein grafts with dipyridamole and aspirin. Am J Cardiol 1979;43:1144-8.
11. Mulder BJ, van der Doef RM, van der Wall EE, et al. Effect of various antithrombotic regimens (aspirin, aspirin plus dipyridamole, anticoagulants) on the functional status of patients and grafts one year after coronary artery bypass grafting. Eur Heart J 1994;15:1129-34.
12. Schneider MD, French BA. The advent of adenovirus. Gene therapy for cardiovascular disease. Circulation 1993;88:1937-42.
13. Lemarchand P, Jones M, Yamada I, Crystal RG. In vivo gene transfer and expression in normal uninjured blood vessels using replication-deficient recombinant adenovirus vectors. Circ Res 1993;72:1132-8.
14. Nabel EG. Gene therapy for cardiovascular disease. Circulation 1995;91:541-8.
15. Chen SJ, Wilson JM, Muller DW. Adenovirus-mediated gene transfer of soluble vascular cell adhesion molecule to porcine interposition vein grafts. Circulation 1994;89:1922-8.
16. Huynh TT, Iaccarino G, Davies MG, Svendsen E, Koch WJ, Hagen PO. Adenoviral-mediated inhibition of G beta gamma signaling limits the hyperplastic response in experimental vein grafts. Surgery 1998;124:177-86.
17. Cable DG, O'Brien T, Schaff HV, Katusic ZS, Pompili VJ. Adenoviral transfection of human saphenous veins with eNOS: gene therapy applied to coronary bypass conduits (abstract). Circulation 1996;94(Suppl 1):295-6.
18. Cable DG, O'Brien T, Kullo IJ, Schwartz RS, Schaff HV, Pompili VJ. Expression and function of a recombinant endothelial nitric oxide synthase gene in porcine coronary arteries. Cardiovasc Res 1997;35:553-9.
19. Cable DG, Caccitolo JA, Pearson PJ, et al. New approaches to prevention and treatment of radial artery graft vasospasm. Circulation 1998;98(Suppl 2):15-21.
20. Cable DG, Caccitolo JA, Pfeifer EA, et al. Endothelial regulation of vascular contraction in radial and internal mammary arteries. Ann Thorac Surg 1999;67:1083-90.
21. Ojha M, Cobbold RS, Johnston KW. Influence of angle on wall shear stress distribution for an end-to-side anastomosis. J Vasc Surg 1994;19:1067-73.
22. Pellegrini C, O'Brien T, Jeppsson A, et al. Influence of temperature on adenovirus-mediated gene transfer. Eur J Cardiothorac Surg 1998;13:599-603.
23. Mann MJ, Gibbons GH, Kernoff RS, et al. Genetic engineering of vein grafts resistant to atherosclerosis. Proc Natl Acad Sci USA 1995;92:4502-6.
24. Bai HZ, Sawa Y, Zhang WD, et al. Gene transfer to vein graft wall by HVJ-liposome method: time course and localization of gene expression. Ann Thorac Surg 1998;66:814-9.
25. Akins CW, Carroll DL. Event-free survival following non-emergency myocardial revascularization during hypothermic fibrillatory arrest. Ann Thorac Surg 1987;43:628-33.
26. βγ inhibitor suggests a major role of G protein signaling in lesion development. Arterioscler Thromb Vasc Biol 1998;18:1275-80.
27. Mann MJ, Whittemore AD, Donaldson MC, et al. Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the prevent single-centre, randomised, controlled trial. Lancet 1999;354:1493-8.
28. Kupfer JM, Ruan XM, Liu G, Matloff J, Forrester J, Chaux A. High-efficiency gene transfer to autologous rabbit jugular vein grafts using adenovirus-transferrin/polylysine-DNA complexes. Hum Gene Ther 1994;5:1437-43.
29. Channon KM, Qian HS, Youngblood SA, et al. Acute host-mediated endothelial injury after adenoviral gene transfer in normal rabbit arteries: impact on transgene expression and endothelial function. Circ Res 1998;82:1253-62.
30. Schulick AH, Newman KD, Virmani R, Dichek DA. In vivo gene transfer into injured carotid arteries. Optimization and evaluation of acute toxicity. Circulation 1995;91:2407-14.